» Articles » PMID: 15021149

The Concept of Curative Margin in Surgery for Bone and Soft Tissue Sarcoma

Overview
Publisher Wolters Kluwer
Specialty Orthopedics
Date 2004 Mar 17
PMID 15021149
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

To clarify the safety margin in excision of bone and soft tissue sarcomas, a new evaluation method for surgical margins was drafted by the Bone and Soft Tissue Committee of the Japanese Orthopaedic Association in 1989. This new evaluation system was applied to 1329 patients with bone and soft tissue sarcomas, of whom 492 were excluded because of insufficient details, leaving 837 patients (901 surgeries) for the current study. Based on the results derived from analyzing these registered surgical margins, predictable safety margins under different conditions could be determined. When preoperative treatment is not done or is ineffective in high-grade sarcoma, a margin greater than 3 cm wide is necessary. When the preoperative modality is effective, a 2-cm wide margin is permissible. However, for recurrent sarcoma, whether low-grade or high-grade, a curative procedure is necessary. For low-grade sarcoma, obtaining an adequate wide margin is essential but partial marginal margins are acceptable at sites where barriers exist. When the margin is insufficient, radiotherapy should be used regardless of the tumor grade. Making a safety margin definitive through this system, an optimum treatment can be obtained and unnecessary adjunctive modalities can be avoided.

Citing Articles

Short-to-Mid-Term Outcomes of Ipsilateral Femoral Head Autograft Combined with Uncemented Total Hip Replacement for Partial Periacetabular Defects Following Tumor Resection.

Xie M, Ye Q, Gong T, Li Z, Wang Y, Lu M Orthop Surg. 2024; 16(12):2950-2959.

PMID: 39324498 PMC: 11608803. DOI: 10.1111/os.14227.


Single-Stage Free Flap Reconstruction Following Extremity Sarcoma Resection: a Regional Cancer Center Experience.

Krishnan C, Ramanujan V, Ramachandran V, Kathiresan N, Raja A Indian J Surg Oncol. 2024; 15(Suppl 1):45-51.

PMID: 38545594 PMC: 10963350. DOI: 10.1007/s13193-023-01713-z.


Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions.

Dong M, Luo H, Liu R, Zhang J, Yang Z, Wang D J Cancer. 2024; 15(3):699-713.

PMID: 38213724 PMC: 10777037. DOI: 10.7150/jca.90371.


A comparative study of reconstruction modalities after knee joint-preserving tumor resection: reconstruction with a custom-made endoprosthesis versus reconstruction with a liquid nitrogen-inactivated autologous bone graft.

Li Y, Xu H, Shan H, Ma K, Liu W, Niu X J Orthop Surg Res. 2023; 18(1):908.

PMID: 38031112 PMC: 10685649. DOI: 10.1186/s13018-023-04402-3.


Distal Humeral Replacement in Patients with Primary Bone Sarcoma: The Functional Outcome and Return to Sports.

Schneider K, Ellerbrock M, Gosheger G, Westphal L, Deventer N, Klingebiel S Cancers (Basel). 2023; 15(13).

PMID: 37444644 PMC: 10340787. DOI: 10.3390/cancers15133534.